Haiyan Wu
Fujian Medical University(CN)Ministry of Education of the People's Republic of China(CN)Inner Mongolia Academy of Agricultural & Animal Husbandry Sciences(CN)Gannan Medical University(CN)First Affiliated Hospital of Fujian Medical University(CN)Women's Hospital, School of Medicine, Zhejiang University(CN)Second Affiliated Hospital of Nanjing Medical University(CN)Second Affiliated Hospital of Zhejiang University(CN)Guangzhou Medical University(CN)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Bioactive Natural Diterpenoids Research, Phytochemistry and Biological Activities, Neuroblastoma Research and Treatments, Prostate Cancer Treatment and Research
Most-Cited Works
- → Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer(2018)2,536 cited
- → Paraneoplastic anti– N ‐methyl‐ D ‐aspartate receptor encephalitis associated with ovarian teratoma(2007)2,443 cited
- → Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study(2019)689 cited
- → Pertuzumab plus trastuzumab and chemotherapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (JACOB): final analysis of a double-blind, randomised, placebo-controlled phase 3 study(2018)472 cited
- → Phosphoinositide 3-Kinase p110β Activity: Key Role in Metabolism and Mammary Gland Cancer but Not Development(2008)263 cited
- → Calpain and Synaptic Function(2006)146 cited